| Product NDC: | 0884-7308 |
| Proprietary Name: | Nalfon |
| Non Proprietary Name: | fenoprofen calcium |
| Active Ingredient(s): | 400 mg/1 & nbsp; fenoprofen calcium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0884-7308 |
| Labeler Name: | Pedinol Pharmacal, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA017604 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20091201 |
| Package NDC: | 0884-7308-03 |
| Package Description: | 3 CAPSULE in 1 BOTTLE, PLASTIC (0884-7308-03) |
| NDC Code | 0884-7308-03 |
| Proprietary Name | Nalfon |
| Package Description | 3 CAPSULE in 1 BOTTLE, PLASTIC (0884-7308-03) |
| Product NDC | 0884-7308 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | fenoprofen calcium |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20091201 |
| Marketing Category Name | NDA |
| Labeler Name | Pedinol Pharmacal, Inc. |
| Substance Name | FENOPROFEN CALCIUM |
| Strength Number | 400 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |